Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Tao Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 18
Average round size
info
The average size of a deal this fund participated in
$38M
Portfolio companies 17
Rounds per year 1.80
Lead investments 2
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.06
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Medical Device

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Tao Capital:
Typical Co-investors
Tao Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Tao Capital:
There are no funds here. If we find new data, we will add it here.

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Challenge IM

Biopharma
Health Care
Medical
10 Oct 2024 Daxing, Beijing, China

Vibronix

Health Diagnostics
Medical Device
$15M24 Jun 2024 Indiana, United States

Rhino Medical

Intellectual Property
Medical
Pharmaceutical
Product Research
$15M27 Dec 2023 -

Huichuang Medical

Health Care
$15M31 Oct 2023 Dongcheng District, Beijing, China

Aorui Bio

Biotechnology
Medical
$15M11 Sep 2023 Hangzhou, Zhejiang, China

Bowang Pharmaceutical

Biotechnology
Product Research
$61M23 Mar 2023 Jiading, Shanghai, China

Siyi Intelligence

Health Care
Medical Device
Rehabilitation
$15M06 Mar 2023 Shanghai, Shanghai, China

TOPI Imaging Technology

Biotechnology
Health Care
$46M20 Dec 2022 Beijing, Beijing, China

4B Technologies

Biopharma
Biotechnology
Health Care
Pharmaceutical
$15M12 Dec 2022 Suzhou, Jiangsu, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Tao Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 18
Average round size 38M
Rounds per year 1.80
Peak activity year 2022
Lead investments 2
Follow on index 0.06
Group Appearance index 0.94

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Challenge IM

Biopharma
Health Care
Medical
10 Oct 2024 Daxing, Beijing, China

Vibronix

Health Diagnostics
Medical Device
$15M24 Jun 2024 Indiana, United States

Rhino Medical

Intellectual Property
Medical
Pharmaceutical
Product Research
$15M27 Dec 2023 -

Huichuang Medical

Health Care
$15M31 Oct 2023 Dongcheng District, Beijing, China

Aorui Bio

Biotechnology
Medical
$15M11 Sep 2023 Hangzhou, Zhejiang, China

Bowang Pharmaceutical

Biotechnology
Product Research
$61M23 Mar 2023 Jiading, Shanghai, China

Siyi Intelligence

Health Care
Medical Device
Rehabilitation
$15M06 Mar 2023 Shanghai, Shanghai, China

TOPI Imaging Technology

Biotechnology
Health Care
$46M20 Dec 2022 Beijing, Beijing, China

4B Technologies

Biopharma
Biotechnology
Health Care
Pharmaceutical
$15M12 Dec 2022 Suzhou, Jiangsu, China
Crunchbase icon

Content report

The following text will be sent to our editors: